BSX vs KZR · P/E 20, rev $20.07B vs $53.9M cap
Boston Scientific Corp (BSX) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. KZR currently screens at market cap $53.9M.
Not investment advice. Open the BSX and KZR stock pages for the full models.
Not investment advice.